Worldwide Blood Plasma Derivatives Market Segments:
The Global Blood Plasma Derivatives Market has been segmented on the basis of type which includes albumin, anti-thrombin, intravenous immunoglobulin (IVIG), fresh frozen plasma (FFP) and others. Others types are Factor VII, Factor IX and Alpha 1 proteinase inhibitor concentrate. On the basis on application the market is segmented into Hemophilia A, Hemophilia B, HIV, Hepatitis B, Hepatitis C, Thrombocytosis, and others. Other application includes Von Willebrand disease. End users include hospitals, clinics, diagnostic centers, blood transfusion centers and others.
The Global Blood Plasma Derivatives Market is expected to reach US$ 58.2 billion in 2023 from US$ 30.5 billion in 2016 with a CAGR of approximately 7.52% during the forecast period 2018-2023. Blood plasma derivatives have a wide range of applications thus increasing their demand in the market. They are used in various diseases like HIV, hepatitis B and Hepatitis C. Plasma derivatives are collected from large number of donors for their use in patients suffering from life threatening diseases. Hence the importance of blood plasma derivatives has increased in healthcare.
Key Players for Blood Plasma Derivatives Market:
Some of the key players in this market are: Grifols (Germany), SK Plasma (Korea), Fusion Healthcare (India), Baxter International Inc. (U.S), CSL Limited (Australia). Other players in this market are Octapharma AG (Germany), Biotest AG (Germany) and Bain Capital (U.S).
Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/1325 .
Regional Analysis of Blood Plasma Derivatives Market:
Globally, Blood Plasma Derivatives market consists of four regions North America, Europe, Asia-Pacific and Middle East and Africa. North America is the largest market for syringe and needle. The North American market for Blood Plasma Derivatives is expected to grow at a CAGR of 4.25% which is expected to reach at US$ 35.50 billion from US$ 20 billion in 2016 by the end of the forecasted period. Awareness regarding use of plasma derivatives for patients suffering from infectious diseases drive this market in North America. Europe is the second-largest market for Blood Plasma Derivatives which is expected to grow at a CAGR of 3.8%. Extensive research on safe blood transfusion in healthcare organizations and research laboratories favor the growth of this market in Europe. India is expected to be the emerging and fastest growing market. Demand for plasma derivatives for inactivation of HIV favor the demand of plasma derivatives in Asia-pacific. The market shows steady growth in Middle East and Africa.
Major Table of Contents for Blood Plasma Derivatives Market Research Report- Global Forecast To 2023:
1 Report Prologue
2 Market Introduction
2.1 Introduction
2.2 Scope Of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Incidences Of Infectious Diseases
4.1.2 Increasing Awareness Use Of Blood Plasma Derivatives In HIV
4.2 Restraints
4.2.1 Safety Concerns During Blood Transfusion
TOC Continued…!
Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/1325 .
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Your information will never be shared with any third party.